Cargando...

Efficacy and safety of interleukin-17A inhibitors in patients with ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials

To assess the efficacy and safety of interleukin (IL)-17A inhibitors in patients with ankylosing spondylitis (AS). PubMed, EMBASE, and Web of Science were searched up to 5 February 2020 for randomized controlled trials (RCTs) that assessed the efficacy and safety of IL-17A inhibitors in patients wit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Rheumatol
Autores principales: Wang, Peng, Zhang, Shuo, Hu, Binwu, Liu, Weijian, Lv, Xiao, Chen, Songfeng, Shao, Zengwu
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8289786/
https://ncbi.nlm.nih.gov/pubmed/33432451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-020-05545-y
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!